Your 360-Degree Life Sciences Executive Search Firm.

Driven to Make a Difference

Direct Target Recruiting
connects you to top talent

Commercial and Clinical

  • Sales
  • Market Access
  • Medical Affairs
  • Clinical

Executive Talent
is not a transaction

Executive Leadership

  • C-Suite
  • Vice President
  • Commercial Leadership

Meet the Team

Experience That Sets Us Apart

Lasting Partnerships.

Our Clients

Agios

Partnership 2024 to present 2024: Expanded the Hematology/Oncology rare disease sales organization to support therapies for rare blood disorders. Placed 3 Regional Business Directors and 25 Hematology Sales Representatives. 2026: Placed 64 additional professionals across the rare disease ecosystem, supporting sickle cell, thalassemia, and hemolytic anemia teams. Searches included Sales, Medical Affairs, Field Access, Patient Support, Clinical Education, Patient Services, and Patient Marketing roles. 92 total placements, including leadership and specialized roles across commercial and patient-facing teams.

Alnylam

Partnership March 2026 - present. Supported Alnylam's expansion of its RNAi therapeutics field organization by placing 135 professionals across commercial, medical affairs, market access, reimbursement, and patient support functions. Key placements included Business Account Executives, Strategic Account Directors, Federal Account Directors, Medical Science Liaisons, Field Reimbursement leaders, Patient Education Liaisons, and Site of Care leadership. This team was built to support disease-state education, patient access initiatives, provider engagement, and strategic stakeholder partnerships across the rare disease landscape. Primary Focus: Rare Disease | RNAi Therapeutics

Travere Therapeutics

Partnership 2022 to present 2022 Expansion of Rare Disease Nephrology sales force to launch Sparsentan which is a treatment for patients with IgAN. Placed 6 Zone Business Directors, 56 Clinical Account Managers (CAM’s), 1 Area Director of Medical Science Liaisons, and 7 Sr. Medical Science Liaisons. 2025 Expansion of Rare Disease FSGS. Placed 2 Sr Business Directors, 6 ZBD’s, 12 Clinical Account Managers, 1 Director, RKD Educator, 6 Thought Leader Liaisons, 6 Access Reimbursement Managers, 6 Strategic Account Managers, 6 Nurse Educators, and 2 Digital Medical Science Liaisons. Primary focus is Rare Disease in Nephrology/Kidney.

Shionogi

Partnership 2020 to present 2020/2021 Expansion of Anti-infective Institutional Sales Force Placed 23+ Key Account Managers and additional KAM Leaders, Associate Director of Sales Operations and Sr. Manager of Training. 2025 Retained for the newly created Primary Care Division. Placed VP/Head of Sales, 2 National Regional Sales Directors (2nd Line leadership.) 2025 Retained for the newly created LTC Division. Placed 2 National Area Business Leaders  (1st Line Leadership.) Primary focus to develop and commercialize pharmaceutical products to treat areas of infectious diseases and pain, as well as other areas of high medical need, including chronic liver disease.

Lantheus

Partnership 2022 - present. Involved with National Expansion Roles for Prostate Cancer / Diagnostic PyLARIFY Radioisotope which included placement of 3 Leadership roles and 30+ Prostate Cancer focused front-line Field Sales force roles.

GE Healthcare

Partnership 2022 - Present Zone Director and Hospital Account Managers

SUPERNUS PHARMACEUTICALS

Partnership 2013 to present 4 Phases of Expansion. Placed Over 185+ Sales Representatives.  Primary focus on ADHD and Parkinson’s Disease.

Takeda Pharmaceuticals

Takeda (Osaka, Japan and Cambridge, MA based 240+ year old Global Pharmaceutical company with core therapeutics in gastrointestinal/inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines). Retained Partner from 2021 – Present. Involved with 2022 National Expansion Roles for Rare Disease Franchise. Successfully placed 20+ Territory Business Managers for Plasma Derivative Therapies/Rare Disease/Neuromuscular Expansion. Primary focus is Neurology and Movement Disorders for (MMN) Multi Motor Neuropathy and upcoming indication HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] for the maintenance treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).

Gilead

Partnership 2020 to Present Placed Placed 6 Sales Reps and 1 Oncology Key Account Director. Oncology Division Primary focus is innovating with next-generation therapies, combinations and technologies to help transform how cancer is treated.

Apellis

Partnership 2021 - Present. Placements for National Expansion of Commercial Team Roles: Two Strategic Account Director – IDNs (East & West) One Senior Director - Strategic Accounts-GPOs, Senior Director – Channel Strategy & Distribution Operations. Successful placement for National Expansion of Leadership Role: Senior Director – National Sales for PNH Division

ACADIA Pharmaceuticals, Inc

Partnership 2018 to Present 2019/2020 Expansion of Sales Force Roles recruited for: Director of Commercial Effectiveness & Training, 2 Long Term Care Area Sales Directors (2nd Line), 4 Neuroscience Area Director roles (2nd Line), 4+ Market Development, Manger roles (Key Accounts/Market Access/KOL), 7 Long Term Care RSMs (1st Line) and 18 Neuroscience RSMs (1st Line)

Allergan Aesthestics

1999 - Present. Placed 100+ Territory Sales Representative positions for this Leading Medical Plastic Surgery and General Surgery Device client on a National basis.

Biodesix

Partnership 2015 to Present Placing Manager of Market Development, VP of Sales (West), National Sales Training Director, and 30+ sales representatives A diagnostic solutions company focusing to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease

AMGEN

Partnership 1995 to Present. Placed 200+ including Oncology Sales Representatives, Regional Sales Managers, District Sales Managers, Institutional Sales Representatives & Corporate Account Manager (Key Accounts) roles in Oncology, Nephrology, Cardiology, etc.

Cardinal Health

Partnership 1/2020 to Present. Roles recruited for: 15 Hospital Sales Executives focused on Cardinal Health Brand Categories (Incontinence, Exam Gloves, Infection Control, Wound Care, and Fluid Management), Performance Plus partnerships and services portfolio at assigned Hospitals, IDNs and Regional Health Systems.

GENENTECH

Partnership 1998 to Present. Placed 200+ Sales Representatives and Leaders within Oncology, Hospital/Institutional, Rheumatology, Neurology, Metabolism, Immunology and Ophthalmology sale and leadership positions.

BD

Hundreds of Executive VP, VP, Director, Strategic Accounts, Field Sales, and Clinical positions filled within BD/Carefusion/Pyxis/Alaris/Medmined since the commencement of our relationship in 1979.

Exact Sciences (Madison, WI based Medical Diagnostic Start-Up)

Partnership 2013 - 2016. Placed their Sales Management Leadership team (over 14 individuals which included 3 Key Account Executives and 11 Area Sales Managers). Our firm has placed over 70+ Sales Representatives for the launch of Cologuard (Diagnostic for Colo-Rectal Cancer) 2013- 2017

AMBRY GENETICS

Recruiting Partnership started in 2018 with this Leading Clinical Genomic Diagnostic client. Currently helping with National Sales Expansion of Oncology and Neurology Divisions with 20+ Field Sales Team, Business Development and Leadership roles.

VERTOS MEDICAL

Partnership 2017 to present. Placed 45+ Sales Directors and Sales Representatives

Success Stories

View More

Your Search is over
Let's talk today